Matreya/N-Dodecanoyl-NBD-ceramide trihexoside/1631/100 ug
Catalog #:1631Scientific Name:N-Dodecanoyl-NBD-ceramide trihexosideCommon Name:N-C12:0-NBD-CTH; N-C12:0-NBD-GlobotriaosylceramideEmpirical Formula:C54H91N5O21SDSView Safety Data SheetData Sheet:View Data SheetFormula Weight:1145Unit:100 ugSolvent:noneSource:semisyntheticPurity:98+%Analytical Methods:TLC; identity confirmed by MSNatural Source:porcine RBCSolubility:DMSO, hot methanol, chloroform/methanol, 2:1Physical Appearance:solidStorage:-20°CDry Ice:NoHazardous:NoLiterature References:1. J. Kok et al. \"Dihydroceramide Biology STRUCTURE-SPECIFIC METABOLISM AND INTRACELLULAR LOCALIZATION” Journal of BiologicalChemistry, Vol. 272 pp. 21128-21136, 19972. J. Hsu et al. \"Enhanced endothelial delivery and biochemical effects of -galactosidase by ICAM-1-targeted nanocarriers for Fabry disease” Journal ofControlled Release, doi:10.1016/j.jconrel.2010.10.031, 20103. J. E. Groener, B. J. Poorthuis, S. Kuiper, M. T. Helmond, C. E. Hollak, J. M. Aerts. \"HPLC for simultaneous quantification of total ceramide,glucosylceramide, and ceramide trihexoside concentrations in plasma.” Clin Chem., Apr;53(4):742-7, 2007. Epub Mar 1 20074. K. Mills, A. Johnson, B. Winchester. \"Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabrydisease by tandem mass spectrometry.” FEBS Lett., Mar 27;515(1-3):171-6, 20025. C. Menge, I. Stamm, M. Wuhrer, R. Geyer, L. H. Wieler, G. Baljer. \"Globotriaosylceramide (Gb(3)/CD77) is synthesized and surface expressed bybovine lymphocytes upon activation in vitro.” Vet Immunol Immunopathol., Nov;83(1-2):19-36, 2001